These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16230489)

  • 1. Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension.
    McCann GP; Beek AM; Vonk-Noordegraaf A; van Rossum AC
    Circulation; 2005 Oct; 112(16):e268. PubMed ID: 16230489
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation.
    Dodge-Khatami A; Büchel EV; Knirsch W; Kadner A; Rousson V; Dave HH; Bauersfeld U; Prêtre R
    Ann Thorac Surg; 2006 Sep; 82(3):983-8. PubMed ID: 16928520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot: a review.
    Oosterhof T; Mulder BJ; Vliegen HW; de Roos A
    Am Heart J; 2006 Feb; 151(2):265-72. PubMed ID: 16442887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants and assessment of pulmonary regurgitation in tetralogy of Fallot: practice and pitfalls.
    Redington AN
    Cardiol Clin; 2006 Nov; 24(4):631-9, vii. PubMed ID: 17098516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging/magnetic resonance angiography of the pulmonary arteries and pulmonary thromboembolic disease.
    Ley S; Kauczor HU
    Magn Reson Imaging Clin N Am; 2008 May; 16(2):263-73, ix. PubMed ID: 18474331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancements in diagnosis of pulmonary arterial hypertension in scleroderma.
    Steen V
    Arthritis Rheum; 2005 Dec; 52(12):3698-700. PubMed ID: 16320319
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for pulmonary arterial hypertension in systemic sclerosis.
    Busteed S; Moots RJ; Thompson RN
    Rheumatology (Oxford); 2004 Oct; 43(10):1315-6; author reply 1316. PubMed ID: 15448224
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
    Hsu VM; Moreyra AE; Wilson AC; Shinnar M; Shindler DM; Wilson JE; Desai A; Seibold JR
    J Rheumatol; 2008 Mar; 35(3):458-65. PubMed ID: 18203320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and therapy of pulmonary hypertension in systemic sclerosis.
    Bull TM
    Curr Opin Rheumatol; 2007 Nov; 19(6):598-603. PubMed ID: 17917541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical approach to screening for scleroderma-associated pulmonary arterial hypertension.
    Fischer A; Bull TM; Steen VD
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):303-10. PubMed ID: 22076819
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
    Sasahara AA
    J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary function test as screening test for pulmonary artery hypertension in scleroderma patients.
    Gupta R
    Rheumatology (Oxford); 2004 Oct; 43(10):1315; author reply 1316. PubMed ID: 15448223
    [No Abstract]   [Full Text] [Related]  

  • 13. Refining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume?
    Wald RM; Redington AN; Pereira A; Provost YL; Paul NS; Oechslin EN; Silversides CK
    Eur Heart J; 2009 Feb; 30(3):356-61. PubMed ID: 19164336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular magnetic resonance: its role in the diagnosis and evaluation of pulmonary arterial hypertension].
    Pamboucas C; Nihoyannopoulos P
    Rev Esp Cardiol; 2006 Aug; 59(8):755-60. PubMed ID: 16938222
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary hypertension: role of computed tomography and magnetic resonance imaging.
    Di Guglielmo L; Dore R; Vespro V
    Ital Heart J; 2005 Oct; 6(10):846-51. PubMed ID: 16270478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].
    Hunzelmann N; Riemekasten G
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S325-7. PubMed ID: 17139598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance.
    Oosterhof T; van Straten A; Vliegen HW; Meijboom FJ; van Dijk AP; Spijkerboer AM; Bouma BJ; Zwinderman AH; Hazekamp MG; de Roos A; Mulder BJ
    Circulation; 2007 Jul; 116(5):545-51. PubMed ID: 17620511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction.
    Torbicki A
    Eur Heart J; 2007 May; 28(10):1187-9. PubMed ID: 17483527
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension.
    Benza R; Biederman R; Murali S; Gupta H
    J Am Coll Cardiol; 2008 Nov; 52(21):1683-92. PubMed ID: 19007687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive cardiac imaging in pulmonary hypertension.
    Sallach SM; Peshock RM; Reimold S
    Cardiol Rev; 2007; 15(2):97-101. PubMed ID: 17303996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.